Formation of the Catecholamine Release-inhibitory Peptide Catestatin from Chromogranin A
Carolyn V. Taylor(Buck Institute for Research on Aging), Daniel T. O’Connor(Nova Southeastern University), Sushil K. Mahata(University of California San Diego), Thomas Toneff(University of California, San Francisco), Laurent Taupenot(University of California San Diego), Manjula Mahata(Uppsala University), Qijiao Jiang(San Francisco VA Medical Center), Sukkid Yasothornsrikul(University of California, San Francisco), Vivian Hook(Harvard University), Haibo Wu, Carlo Caporale, Robert J. Parmer(Buck Institute for Research on Aging)
Cited by 75
Related Papers
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
The Chromogranin–Secretogranin Family
|New England Journal of Medicine|2003|820
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
|New England Journal of Medicine|1986|484
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
|Journal of Clinical Investigation|1997|399
Assessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder Risk
|JAMA Psychiatry|2014|391